Related Experiment Video
Updated: Feb 25, 2026

Constructing Mutants in Serotype 1 Streptococcus pneumoniae strain 519/43
Published on: September 11, 2020
Key features of invasive pneumococcal isolates recovered in Lima, Peru determined through whole genome sequencing
Paulina Hawkins1, Erik Mercado2, Sopio Chochua3
1Emory University, Atlanta, USA; Centers for Disease Control and Prevention, Atlanta, USA.
Insights
Pneumococcal conjugate vaccine 7 (PCV7) introduction in Peru altered invasive pneumococcal disease (IPD) serotype distribution and reduced PCV7 serotype prevalence. Antimicrobial resistance remained high, with emerging non-vaccine serotypes showing resistance.
Area of Science:
- Microbiology
- Genomics
- Epidemiology
Background:
- Invasive pneumococcal disease (IPD) caused significant child mortality in Latin America before vaccine introduction.
- Peru introduced the 7-valent pneumococcal conjugate vaccine (PCV7) in 2009 to combat IPD.
- Understanding the impact of PCV7 on circulating strains and antimicrobial resistance is crucial for public health.
Purpose of the Study:
- To analyze the genomic features of invasive pneumococcal isolates in Lima, Peru, before and after PCV7 introduction.
- To identify changes in serotype prevalence, sequence types (STs), and antimicrobial resistance patterns post-PCV7 implementation.
Main Methods:
- Whole genome sequencing of 212 IPD isolates collected from 2006 to 2011 in Lima, Peru.
- Bioinformatic analysis using CDC's Streptococcus pipeline to determine serotypes, STs, pilus genes, and resistance determinants.
- Comparison of isolate characteristics between the pre-PCV7 (2006-2009) and post-PCV7 (2010-2011) periods.
Main Results:
- A significant decrease in PCV7 serotype 6B was observed post-introduction (24.8% to 6.3%).
- Non-vaccine serotypes 19F and 19A showed increased prevalence post-PCV7.
- High rates of antimicrobial resistance determinants were found in 82% of isolates, with 34% carrying resistance to multiple drug classes.
Conclusions:
- PCV7 introduction effectively reduced the prevalence of vaccine-targeted serotypes in Peru.
- Emerging non-vaccine serotypes, particularly 19F and 19A, are becoming dominant and carry significant antimicrobial resistance.
- Continued genomic surveillance is essential to monitor IPD trends and inform vaccination and treatment strategies.
Abstract:
Before PCV7 introduction, invasive pneumococcal disease (IPD) was responsible for approximately 12,000-18,000 deaths annually among children <5years in Latin America. In Peru, PCV7 was introduced in 2009. We used whole genome sequencing to deduce key features of invasive strains collected in Lima, Peru from 2006 to 2011. We sequenced 212 IPD isolates from 16 hospitals in Lima pre (2006-2009; n=133) and post (2010-2011; n=79) PCV7 introduction; 130 (61.3%) isolates were from children≤5years old. CDC's Streptococcus lab bioinformatics pipeline revealed serotypes, sequence types (STs), pilus genes, PBP types and other resistance determinants. During the pre-PCV7 period, serotype 14 was the most common serotype (24.8%), followed by 6B (20.3%), 19F (10.5%), and 23F (6.8%). Post-PCV7, the proportion of PCV7 serotype 6B decreased significantly (to 6.3%), while 19F (16.3%), 14 (15.0%), 23F (7.5%), and 19A (7.5%) were the most common serotypes; only serotypes 3 and 10A increased significantly. Overall, 82% (n=173) of all isolates carried at least one resistance determinant, including 72 (34%) isolates that carried resistance determinants against 3 or more antimicrobial classes; of these 72 isolates, 56 (78%) belonged to a PCV7 serotype. Eighty-two STs were identified, with 53 of them organized in 14 clonal complexes. ST frequencies were distributed differently pre and post-PCV7 introduction, with only 18 of the 57 STs identified in years 2006-2009 isolates also observed in years 2010-2011 isolates. The apparent expansion of a 19F/ST1421 lineage with predicted β-lactam resistance (PBP type 13:16:20) and carrying resistance determinants against four additional antimicrobial classes was observed.
More Related Videos
09:44Characterization of a Pathogenic Escherichia coli Strain Derived from Oreochromis spp. Farms Using Whole-Genome Sequencing
Published on: December 23, 2022
11:32Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014